Literature DB >> 34398400

Comparison of open and a novel closed vitrification system with slow freezing for human ovarian tissue cryopreservation.

Yodo Sugishita1,2,3, Enes Taylan1, Tai Kawahara1,2, Bunyad Shahmurzada1, Nao Suzuki2, Kutluk Oktay4.   

Abstract

PURPOSE: To investigate the differences concerning post-thawing/warming follicle survival, DNA damage and apoptosis in human ovarian tissues cryopreserved by slow freezing, open, or closed vitrification methods.
METHODS: A total of 50 pieces of 5 × 5 × 1 mm ovarian cortical pieces were harvested (5 donor ovaries; mean age 31 ± 6.62 years). From each donor, one cortical piece was used as baseline; the remaining were randomly assigned to slow freezing (SF), vitrification using open device (VF-open), or closed device (VF-closed) groups. After 8-10 weeks of cryostorage, tissues were evaluated 4 h after thawing/warming. Histological analysis was evaluated for follicle survival (primordial and primary follicle densities) by H&E staining. The percentages of primordial and primary follicles with DNA double-strand breaks (γH2AX) and apoptotic cell death pathway activation (AC3) were immunohistochemically assessed. Data were analysed using one-way ANOVA and LSD post hoc comparison.
RESULTS: Compared to the baseline, primordial follicle (pdf) densities significantly declined in all cryopreserved groups (SF, VF-open, and VF-closed, P < 0.05). However, the total and non-apoptotic pdf densities were similar among SF, VF-open, and VF-closed. SF and VF with either open or closed devices did not increase the percentages of primordial or primary follicles with DNA double-strand breaks (DSBs) or apoptosis compared to the baseline or among the freezing methods in the present study.
CONCLUSION: Based on the intact primordial follicle survival, DNA damage, and apoptosis rates after thawing/warming, SF vs VF with either open or newly developed closed devices appear to be comparable.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Fertility preservation; Follicle survival; Ovarian reserve; Ovarian tissue cryopreservation; Slow freezing; Vitrification

Mesh:

Substances:

Year:  2021        PMID: 34398400      PMCID: PMC8581089          DOI: 10.1007/s10815-021-02297-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  60 in total

Review 1.  A review of the risk of contamination of semen and embryos during cryopreservation and measures to limit cross-contamination during banking to prevent disease transmission in ET practices.

Authors:  A Bielanski
Journal:  Theriogenology       Date:  2011-09-29       Impact factor: 2.740

2.  Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients.

Authors:  Jack Yu Jen Huang; Ri-Cheng Chian; Lucy Gilbert; David Fleiszer; Hananel Holzer; Ezgi Dermitas; Shai Elazar Elizur; Yariv Gidoni; Dan Levin; Weon-Young Son; Seang Lin Tan
Journal:  Am J Surg       Date:  2010-07       Impact factor: 2.565

3.  Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2013-10-02       Impact factor: 7.329

4.  Vitrification of human ovarian tissue: effect of different solutions and procedures.

Authors:  Christiani Andrade Amorim; Anu David; Anne Van Langendonckt; Marie-Madeleine Dolmans; Jacques Donnez
Journal:  Fertil Steril       Date:  2010-12-18       Impact factor: 7.329

5.  Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm.

Authors:  K Oktay; K Economos; M Kan; J Rucinski; L Veeck; Z Rosenwaks
Journal:  JAMA       Date:  2001-09-26       Impact factor: 56.272

6.  Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.

Authors:  Francisca Martinez
Journal:  Fertil Steril       Date:  2017-07-21       Impact factor: 7.329

7.  Successful vitrification of bovine and human ovarian tissue.

Authors:  Noriko Kagawa; Sherman Silber; Masashige Kuwayama
Journal:  Reprod Biomed Online       Date:  2009-04       Impact factor: 3.828

8.  Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise.

Authors:  Reza Soleimani; Elke Heytens; Zbigniew Darzynkiewicz; Kutluk Oktay
Journal:  Aging (Albany NY)       Date:  2011-08       Impact factor: 5.682

9.  Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation.

Authors:  Giovanna Fasano; Federica Moffa; Julie Dechène; Yvon Englert; Isabelle Demeestere
Journal:  Reprod Biol Endocrinol       Date:  2011-11-23       Impact factor: 5.211

10.  Cryopreservation and transplantation of ovarian tissue: results from one center in the USA.

Authors:  Sherman J Silber; Michael DeRosa; Sierra Goldsmith; Yuting Fan; Leilani Castleman; Jeffrey Melnick
Journal:  J Assist Reprod Genet       Date:  2018-09-25       Impact factor: 3.412

View more
  4 in total

1.  The effect of high-throughput vitrification of human ovarian cortex tissue on follicular viability: a promising alternative to conventional slow freezing?

Authors:  Andreas Schallmoser; Rebekka Einenkel; Cara Färber; Norah Emrich; Julia John; Nicole Sänger
Journal:  Arch Gynecol Obstet       Date:  2022-09-29       Impact factor: 2.493

2.  Fertility preservation strategies for cancerous women: An updated review.

Authors:  Fatemeh Anbari; Mohammad Ali Khalili; Maryam Mahaldashtian; Alireza Ahmadi; Maria Grazia Palmerini
Journal:  Turk J Obstet Gynecol       Date:  2022-06-27

3.  The effect of different vitrification protocols on cell survival in human ovarian tissue: a pilot study.

Authors:  J Marschalek; C Egarter; K Nouri; S Dekan; J Ott; M Frank; D Pietrowski
Journal:  J Ovarian Res       Date:  2021-12-06       Impact factor: 4.234

Review 4.  Ovarian tissue bank for fertility preservation and anti-menopause hormone replacement.

Authors:  Jing Chen; Yan Han; Wenjie Shi; Xiaohong Yan; Yingying Shi; Ye Yang; Hong Gao; Youzhu Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.